Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group.

Journal of neurosurgery - 1 Apr 2022

Mineharu Yohei, Takagi Yasushi, Koizumi Akio, Morimoto Takaaki, Funaki Takeshi, Hishikawa Tomohito, Araki Yoshio, Hasegawa Hitoshi, Takahashi Jun C, Kuroda Satoshi, Houkin Kiyohiro, Miyamoto Susumu

Abstract excerpt

OBJECTIVE: Although many studies have analyzed risk factors for contralateral progression in unilateral moyamoya disease, they have not been fully elucidated. The aim of this study was to examine whether genetic factors as well as nongenetic factors are involved in the contralateral progression. METHODS: The authors performed a multicenter cohort study in which 93 cases with unilateral moyamoya disease were...

Topics

Join the communities discussing this publication.

Adenosine Triphosphatases
Child
Cohort Studies
Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Moyamoya Disease

Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 34507293
DOI: 10.3171/2021.3.JNS203913

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group.PMID 34507293Read ↗

RNF213 R4810K Variant in Suspected Unilateral Moyamoya Disease Predicts Contralateral Progression.Semantic proximity Read ↗

Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.Semantic proximity Read ↗

Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.Semantic proximity Read ↗

Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.Semantic proximity Read ↗

Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients.Semantic proximity Read ↗

Moyamoya disease: diagnosis and interventions.Semantic proximity Read ↗

Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?Semantic proximity Read ↗

Rapid contralateral progression of focal cerebral arteriopathy distinguished from RNF213-related moyamoya disease and fibromuscular dysplasia.Semantic proximity Read ↗

Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.Semantic proximity Read ↗

Impact of RNF213 Founder Polymorphism (p.R4810K) on the Postoperative Development of Indirect Pial Synangiosis After Direct/indirect Combined Revascularization Surgery for Adult Moyamoya Disease.Semantic proximity Read ↗

RNF213 p.Arg4810Lys Heterozygosity in Moyamoya Disease Indicates Early Onset and Bilateral Cerebrovascular Events.Semantic proximity Read ↗

Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.